Comparison | Subgroup | Sample size | Test of association | |||
---|---|---|---|---|---|---|
Studies | case/control | RRs (95% CIs) | z | P | ||
allele C vs. allele A | overall | 10 | 2951/3527 | 1.05 (0.99, 1.11) | 1.60 | 0.109 |
UK | 5 | 1257/1407 | 1.08 (0.99, 1.17) | 1.79 | 0.073 | |
Caucasian | 8 | 2225/2858 | 1.04 (0.98, 1.10) | 1.22 | 0.222 | |
adenomatous polyps | 9 | 2934/3451 | 1.04 (0.99, 1.10) | 1.48 | 0.138 | |
CC vs. AA | overall | 10 | 2951/3527 | 1.15 (0.98, 1.35) | 1.69 | 0.091 |
UK | 5 | 1257/1407 | 1.27 (1.02, 1.57) | 2.14 | 0.032 | |
Caucasian | 8 | 2225/2858 | 1.14 (0.96, 1.35) | 1.50 | 0.133 | |
adenomatous polyps | 9 | 2934/3451 | 1.14 (0.97, 1.34) | 1.58 | 0.114 | |
AC vs. AA | overall | 10 | 2951/3527 | 1.02 (0.96, 1.08) | 0.63 | 0.528 |
UK | 5 | 1257/1407 | 1.02 (0.93, 1.11) | 0.39 | 0.698 | |
Caucasian | 8 | 2225/2858 | 1.01 (0.95, 1.07) | 0.25 | 0.805 | |
adenomatous polyps | 9 | 2934/3451 | 1.02 (0.96, 1.08) | 0.56 | 0.576 | |
AC + CC vs. AA | overall | 10 | 2951/3527 | 1.03 (0.98, 1.08) | 1.13 | 0.258 |
UK | 5 | 1257/1407 | 1.04 (0.97, 1.12) | 1.08 | 0.279 | |
Caucasian | 8 | 2225/2858 | 1.02 (0.97, 1.08) | 0.72 | 0.471 | |
adenomatous polyps | 9 | 2934/3451 | 1.03 (0.98, 1.08) | 1.03 | 0.303 | |
CC vs. AA + AC | overall | 10 | 2951/3527 | 1.15 (0.97, 1.36) | 1.64 | 0.100 |
UK | 5 | 1257/1407 | 1.27 (1.02, 1.60) | 2.10 | 0.036 | |
Caucasian | 8 | 2225/2858 | 1.14 (0.96, 1.36) | 1.49 | 0.135 | |
adenomatous polyps | 9 | 2934/3451 | 1.14 (0.97, 1.35) | 1.55 | 0.122 | |
carrier C vs. carrier A | overall | 10 | 2951/3527 | 1.03 (0.97, 1.09) | 0.96 | 0.336 |
UK | 5 | 1257/1407 | 1.04 (0.96, 1.14) | 1.00 | 0.318 | |
Caucasian | 8 | 2225/2858 | 1.02 (0.96, 1.09) | 0.68 | 0.499 | |
adenomatous polyps | 9 | 2934/3451 | 1.03 (0.97, 1.09) | 0.88 | 0.376 |